CLINICAL STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common heart drug boost cancer treatment?
Disease control Recruiting nowThis study tests whether adding propranolol (a beta-blocker used for heart conditions) to standard chemotherapy and immunotherapy (pembrolizumab) can improve treatment response in people with advanced esophageal or gastroesophageal junction cancer that cannot be surgically remove…
Matched conditions: CLINICAL STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Ear seeds may curb cancer appetite loss
Symptom relief Recruiting nowThis study tests whether a simple, non-invasive technique called auricular acupressure (using small pellets on the ear) can improve appetite and prevent weight loss in people with advanced stomach, esophageal, or pancreatic cancer. Researchers will enroll 66 patients to see if th…
Matched conditions: CLINICAL STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC